The Drug Abuse Warning Network (DAWN) 2022 Findings on Drug-Related Emergency Related Visits presents national estimates of drug- related...
Archive for category: Research & Publications
The International Narcotic Control Board (INCB) recently published the 2022 Precursors Annual Report, which describes trends in the trade...
US: Vital Statistics Rapid Release: Provisional drug overdose death counts
Lisa McElhaney / / / News Alert, Research & PublicationsEarlier this week, the CDC released updated provisional drug overdose death counts based on data from the National Vital...
US: CDC issues new opioid prescribing guidance, giving doctors more leeway to treat pain
Lisa McElhaney / / / News Alert, Opioids, Research & PublicationsThe Centers for Disease Control and Prevention has issued new guidance for clinicians on how and when to prescribe...
US: Meaning of “Good Faith” Efforts under Controlled Substances Act Determined by U.S. Supreme Court
Lisa McElhaney / / / Research & PublicationsU.S. Supreme Court Ruling – “Good Faith” As reported by LAPPA (August 2022) Xiulu Ruan v. United States, U.S....
US: Bromazolam Prevalence Surgining Across the United States
Lisa McElhaney / / / Research & PublicationsNPS Discovery would like to notify you about new information regarding the new benzodiazepine Bromazolam. Identifications for this benzodiazepine...
How a Large AMC Took a Proactive Approach to Drug Diversion Monitoring
Lisa McElhaney / / / Research & Publicationsby Amanda Rogers, Marketing Content Writer, Protenus on June 14, 2022 Detecting and monitoring drug diversion using manual processes and disjointed...
US: Online “Nootropics” Sellers Sentanced for Selling Misbranded and Unapproved Drugs
Lisa McElhaney / / / Research & PublicationsU.S. District Court Ruling – Misbranded & Unapproved Drugs – Tianeptine As reported by LAPPA (August 2022) United States...
VA: Hospital Settles Controlled Substance Act Violations for $4.36 Million
Lisa McElhaney / / / Research & PublicationsU.S. District Court Ruling – Misbranded & Unapproved Drugs – Tianeptine As reported by LAPPA (August 2022) In Re:...
US: Preliminary Findings from Drug-Related Emergency Department Visits, 2021 (DAWN)
Lisa McElhaney / / / Research & PublicationsAn analysis of 2021 preliminary data presents (1) nationally representative weighted estimates for the top five drugs in drug-related...
Membership Account
Latest NADDI News
- TX: Court Prohibits Two Texas Physicians from Prescribing Opioids and Imposes $1.2M in Civil Penalties for Alleged Unlawful Opioid Distribution October 10, 2024
- LA: Alleged drug dealer arrested with 600 lethal doses of fentanyl, $4K in cash after investigation into fatal overdose October 8, 2024
- Ten Pharmaceutical Distributor Executives, Sales Representatives, and Brokers Charged in Connection with Unlawful Sales of Nearly 70M Opioid Pills October 3, 2024